4/A//SEC Filing
Russell Angus C. 4/A
Accession 0001479290-22-000071
CIK 0001479290other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:17 PM ET
Size
5.9 KB
Accession
0001479290-22-000071
Insider Transaction Report
Form 4/AAmended
Russell Angus C.
Director
Transactions
- Award
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 totalExercise: $18.12Exp: 2032-05-03→ Common Stock (10,756 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Mr. Russell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual grant pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001534002
Filing Metadata
- Form type
- 4/A
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:17 PM ET
- Size
- 5.9 KB